Company profile
myNEO Therapeutics
Innovating immunotherapies, transforming tomorrow.
- Industry
- Biotechnology Research
- Employees
- 18
- Headquarters
- Ghent, Flemish Region
- Founded
- 2018
- LinkedIn followers
- 3,827
- Office locations
- 1
myNEO Therapeutics company summary
myNEO Therapeutics is a company in the Biotechnology Research industry, headquartered in Ghent, Flemish Region, founded in 2018. On LinkedIn the company has around 18 employees and 3,827 followers. Its listed specialties include immunotherapy, big data, cancer vaccine, dark genome, AI.
What technology does myNEO Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About myNEO Therapeutics
myNEO Therapeutics is a distinguished biopharmaceutical powerhouse, dedicated to pioneer breakthrough immunotherapies to fight cancer. myNEO Therapeutics is leveraging its ImmunoEngine discovery platform to tap into novel promising tumor targets found in the dark genome – named camyotopes™ – which have the potential to unlock immunotherapy for large patient populations who currently do not respond. In parallel, the service angle of myNEO Therapeutics, myNEO Intelligence, assists biopharma companies in transforming their decision-making process from trial & error to data-driven decisions using an AI-powered platform. Deriving insights from its expansive library of clinical and molecular data, myNEO Intelligence maps the molecular profiling of cancer patients at an individual level and then correlates the different data points to make data-driven decisions across the drug development life cycle. myNEO Intelligence can identify novel targets and biomarkers, prioritize drug candidates and indications, stratify patient populations and predict treatment response.
Specialties
Where is myNEO Therapeutics located?
myNEO Therapeutics lists 1 location.
Compare companies similar to myNEO Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
myNEO Therapeutics myneotx.com | Biotechnology Research | 18 | 2018 | Ghent, Flemish Region |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about myNEO Therapeutics
What does myNEO Therapeutics do?
myNEO Therapeutics is a distinguished biopharmaceutical powerhouse, dedicated to pioneer breakthrough immunotherapies to fight cancer. myNEO Therapeutics is leveraging its ImmunoEngine discovery platform to tap into novel promising tumor targets found in the dark genome – named camyotopes™ – which have the potential to unlock immunotherapy for large patient populations who currently do not respond. In parallel, the service angle of myNEO Therapeutics, myNEO Intelligence, assists biopharma companies in transforming their decision-making process from trial & error to data-driven decisions using an AI-powered platform. Deriving insights from its expansive library of clinical and molecular data, myNEO Intelligence maps the molecular profiling of cancer patients at an individual level and then correlates the different data points to make data-driven decisions across the drug development life cycle. myNEO Intelligence can identify novel targets and biomarkers, prioritize drug candidates and indications, stratify patient populations and predict treatment response.
How many employees does myNEO Therapeutics have?
myNEO Therapeutics has around 18 employees on LinkedIn.
Where is myNEO Therapeutics headquartered?
myNEO Therapeutics is headquartered in Ghent, Flemish Region.
When was myNEO Therapeutics founded?
myNEO Therapeutics was founded in 2018.
Build a lead list from companies like myNEO Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.